CooperVision® Myopia Management Center
A closer look at pediatric myopia.

 

A growing concern that CooperVision will help address

More than 40% of Americans are myopic and that number is increasing at an alarming rate, especially among school-aged children.1 Two-thirds of eye care professionals (66%) say the presence of myopia among children in their practice has increased over the past 5-10 years2, and 81% of ECPs agree that myopia is one of the biggest problems impacting children’s eyesight today.2

 

Myopia isn't going anywhere on its own
The upward incidence of myopia in today’s children can be attributed to different factors, and is occasionally the result of a combination of these factors:

Genetics

Family eyesight history plays a role in a child’s risk of myopia. If neither parent is myopic, the chance the child will develop myopia is low. But, if one parent is myopic, it increases the child’s chance of developing myopia by 3x – doubling to 6x if both parents are myopic.3

Environment

Exposure to sunlight, vitamin D intake, dopamine levels and the amount of time someone spends outdoors have an impact on an individual’s likelihood of being myopic. Research shows spending more time outdoors lowers the risk of childhood myopia.3

In short, more myopic parents means more myopic children – and the more they
stay inside and utilize digital devices, the more likely we are to see new myopes.

 

Absence of urgency around myopia can create future risks

56% of ECPs agree that myopia, left untreated, increases the risk of irreversible vision loss later in life2. Even children with fairly mild prescriptions have a higher risk of glaucoma and retinal detachment compared to non-myopic children, and that risk multiplies as their prescriptions get stronger.


Myopic progression has been linked to sight-threatening conditions later in life such as5:

• Glaucoma
• Retinal detachment
• Myopic maculopathy

A modern approach to pediatric myopia management

With the FDA approval of MiSight® 1 day, CooperVision continues bringing innovation to eye health. U.S. eye care professionals soon will be able join their colleagues from other parts of the world in taking on the growing prevalence and severity of pediatric myopia with a proven approach specifically designed for the challenge.

Sign up for Updates

MiSight® 1 day will launch as the cornerstone of a comprehensive CooperVision myopia management initiative in Spring 2020 through eye care professional offices nationwide. Register now to receive more information about this program as it becomes available.

*Indications for Use: MiSight® (omafilcon A) daily wear single use Soft Contact Lenses are indicated for the correction of myopic ametropia and for slowing the progression of myopia in children with non-diseased eyes, who at the initiation of treatment are 8-12 years of age and have a refraction of -0.75  to -4.00 diopters (spherical equivalent) with ≤ 0.75 diopters of astigmatism. The lens is to be discarded after each removal.

1. Cooper, Y. (2019, May 1). With Childhood Myopia Rates on the Rise, the American Optometric Association Highlights the Importance of Early Intervention through Annual Eye Exams. Retrieved from https://www.aoa.org/newsroom/myopia-rates-on-the-rise-syvm

2. CooperVision data on file 2019. Myopia Awareness, The Harris Poll online survey of n= 1,005 parents (with child age 8-15) and n=313 ECPs (who see at least 1 child age 8-15 with myopia each month) in U.S.

3. Gifford, P., & Gifford, K. L. (2016). The Future of Myopia Control Contact Lenses. Optometry and Vision Science. 93(4): 336-343.

4. Xu L, Wang Y, Wang S, Wang Y & Jonas JB, ‘High Myopia and Glaucoma Susceptibility: The Beijing Eye Study’ Ophthalmology, Volume 114, Issue 2, February 2007; Praveen MR,Shah GD, Vasavada AR, Mehta PG, Gilbert.

5. Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31(6):622-660.